Gansané, Adama
Moriarty, Leah F.
Ménard, Didier
Yerbanga, Isidore
Ouedraogo, Esperance
Sondo, Paul
Kinda, Rene
Tarama, Casimir
Soulama, Edwige
Tapsoba, Madou
Kangoye, David
Compaore, Cheick Said
Badolo, Ousmane
Dao, Blami
Tchwenko, Samuel
Tinto, Halidou
Valea, Innocent
Clinical trials referenced in this document:
Documents that mention this clinical trial
Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017–2018
https://doi.org/10.1186/s12936-021-03585-6
Funding for this research was provided by:
USAID
Article History
Received: 19 October 2020
Accepted: 7 January 2021
First Online: 19 January 2021
Ethics approval and consent to participate
: The study protocol was approved by the Institutional Ethics Committee of CNRFP and the Health Research Ethics Committee of Burkina Faso and was conducted in accordance with International Conference on Harmonization and Good Clinical Practices. The study was approved by the Regulatory authority from the Ministry of Health. Parents or guardians provided written informed consent for their children to participate in the study.
: All co-authors have no conflicts of interest to declare.